NL7801187A - Farmaceutisch tablet. - Google Patents

Farmaceutisch tablet.

Info

Publication number
NL7801187A
NL7801187A NL7801187A NL7801187A NL7801187A NL 7801187 A NL7801187 A NL 7801187A NL 7801187 A NL7801187 A NL 7801187A NL 7801187 A NL7801187 A NL 7801187A NL 7801187 A NL7801187 A NL 7801187A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical tablet
tablet
pharmaceutical
Prior art date
Application number
NL7801187A
Other languages
English (en)
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of NL7801187A publication Critical patent/NL7801187A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7801187A 1977-03-04 1978-02-02 Farmaceutisch tablet. NL7801187A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/774,279 US4122157A (en) 1977-03-04 1977-03-04 Nitrofurantoin sustained release tablet

Publications (1)

Publication Number Publication Date
NL7801187A true NL7801187A (nl) 1978-09-06

Family

ID=25100770

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7801187A NL7801187A (nl) 1977-03-04 1978-02-02 Farmaceutisch tablet.

Country Status (12)

Country Link
US (1) US4122157A (nl)
JP (1) JPS53109932A (nl)
AU (1) AU510924B2 (nl)
BE (1) BE864349A (nl)
CA (1) CA1090254A (nl)
DE (1) DE2808514A1 (nl)
FR (1) FR2382235A1 (nl)
GB (1) GB1551698A (nl)
IL (1) IL53851A (nl)
NL (1) NL7801187A (nl)
PH (1) PH14916A (nl)
ZA (1) ZA78269B (nl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4673405A (en) * 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
CN1003978B (zh) * 1987-09-05 1989-04-26 广州陈李济药厂 一种补脾益肠丸的制备工艺
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5453281A (en) * 1992-03-17 1995-09-26 Lafayette Applied Chemistry, Inc. Compositions utilizing small granule starch
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
WO1998006385A1 (de) * 1996-08-15 1998-02-19 Losan Pharma Gmbh Gut schluckbare orale arzneiform
RU2309733C2 (ru) * 1999-08-20 2007-11-10 Ферросан А/С Фармацевтическая система доставки витамина с и витамина е и применение комбинации витаминов с и е для профилактики или лечения состояний, связанных с окислительной нагрузкой
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
BR0007360A (pt) * 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
AU2003255890A1 (en) * 2002-08-23 2004-03-11 Ranbaxy Laboratories Limited Nitrofurantoin controlled release dosage form
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
TW200524541A (en) * 2003-11-17 2005-08-01 Cargill Inc Lecithin-containing granular compositions and methods of their preparation
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
EP2034953A4 (en) * 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
IT201900000897A1 (it) * 2019-01-22 2020-07-22 Phf S A Formulazione a rilascio prolungato a permanenza gastrica a base di nitrofurantoina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3388041A (en) * 1964-01-27 1968-06-11 Richardson Merrell Inc High dosage sustained release tablet
DE2050701C3 (de) 1969-10-17 1979-12-20 Shinetsu Chemical Co., Tokio Verwendung eines pulverförmigen Celluloseäthers als Hilfsstoff zur Herstellung von leicht zerfallbaren festen Arzneiformen
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
GB1279214A (en) 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier
FR2100858B1 (nl) 1970-07-03 1975-06-06 Daiichi Seiyaku Co
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
ZA739543B (en) 1973-02-16 1975-03-26 Hoffmann La Roche Free-flowing, directly tablettable, pharmaceutically active substances

Also Published As

Publication number Publication date
PH14916A (en) 1982-01-29
US4122157A (en) 1978-10-24
GB1551698A (en) 1979-08-30
CA1090254A (en) 1980-11-25
AU3260278A (en) 1979-07-26
DE2808514A1 (de) 1978-09-07
AU510924B2 (en) 1980-07-17
IL53851A (en) 1980-09-16
FR2382235B1 (nl) 1981-07-31
BE864349A (fr) 1978-06-16
FR2382235A1 (fr) 1978-09-29
JPS53109932A (en) 1978-09-26
ZA78269B (en) 1979-01-31
IL53851A0 (en) 1978-04-30

Similar Documents

Publication Publication Date Title
NL7801187A (nl) Farmaceutisch tablet.
DK137878A (da) Tabletopbygning
NL189175C (nl) Eenheidsdosistablet.
NL7815003A (nl) Wasmiddeltablet.
NL7805964A (nl) Medicinaal produkt.
NO781786L (no) Terapeutisk middel.
NL7714308A (nl) Injectiespuit.
NL7711426A (nl) Injectiespuit.
NL7614262A (nl) Kauwbare tablet.
NO803313L (no) Tablett.
NL7709425A (nl) Rietbalkeenheid.
NL7711446A (nl) Pharmaceutische desinfecterend preparaat.
NL7809677A (nl) Fotografisch product.
IT7821686A0 (it) Composizione farmaceutica.
NO147437C (no) Partikkelformig forstoff for droevtyggere.
NO143608C (no) Tablettknuser.
FI783223A (fi) Pyrazinobensoxatsepinderivat, foerfaranden foer deras framstaellning och desamma innehaollande farmaceutiska blandningar
NO790313L (no) Farmasoeytisk opploesning.
NL7810618A (nl) Vuil-vrijmakende middelen.
FI763506A (fi) Farmaceutisk naeringsfoerpackning
NL7801921A (nl) Farmaceutische preparaten.
NL7801464A (nl) Farmaceutische samenstellingen.
NL7803333A (nl) Geneesmiddel tegen diarree.
NL7808864A (nl) Injectiespuit.
NL7805158A (nl) Farmaceutisch preparaat.

Legal Events

Date Code Title Description
BV The patent application has lapsed